glp-1 deficiency Nutritional Deficiencies with weekly Receptor Agonists (Ozempic & Mounjaro): What patients Need to Know GLP-1 Agonists In Obesity

Patients should work collaboratively with healthcare teams including physicians, dietitians, exercise specialists, and behavioral health professionals to develop comprehensive, individualized weight management plans

34 The trial had a total of 731 patients with a baseline mean A1C of 8.2% and a baseline total daily dose of insulin ranging from 56 to 62 units, depending on the treatment group

It's important to note that these NHS commissioning criteria are more restrictive than the licensed indications, which permit use at lower BMI thresholds

But the rest of the road is unpaved

I explore the research on GLP-1s and Alzheimers here

-Regul., Integr